<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">37029117</PMID><DateCompleted><Year>2023</Year><Month>04</Month><Day>11</Day></DateCompleted><DateRevised><Year>2024</Year><Month>09</Month><Day>16</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">2041-1723</ISSN><JournalIssue CitedMedium="Internet"><Volume>14</Volume><Issue>1</Issue><PubDate><Year>2023</Year><Month>Apr</Month><Day>07</Day></PubDate></JournalIssue><Title>Nature communications</Title><ISOAbbreviation>Nat Commun</ISOAbbreviation></Journal><ArticleTitle>Data-driven analysis to understand long COVID using electronic health records from the RECOVER initiative.</ArticleTitle><Pagination><StartPage>1948</StartPage><MedlinePgn>1948</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">1948</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1038/s41467-023-37653-z</ELocationID><Abstract><AbstractText>Recent studies have investigated post-acute sequelae of SARS-CoV-2 infection (PASC, or long COVID) using real-world patient data such as electronic health records (EHR). Prior studies have typically been conducted on patient cohorts with specific patient populations which makes their generalizability unclear. This study aims to characterize PASC using the EHR data warehouses from two large Patient-Centered Clinical Research Networks (PCORnet), INSIGHT and OneFlorida+, which include 11 million patients in New York City (NYC) area and 16.8 million patients in Florida respectively. With a high-throughput screening pipeline based on propensity score and inverse probability of treatment weighting, we identified a broad list of diagnoses and medications which exhibited significantly higher incidence risk for patients 30-180 days after the laboratory-confirmed SARS-CoV-2 infection compared to non-infected patients. We identified more PASC diagnoses in NYC than in Florida regarding our screening criteria, and conditions including dementia, hair loss, pressure ulcers, pulmonary fibrosis, dyspnea, pulmonary embolism, chest pain, abnormal heartbeat, malaise, and fatigue, were replicated across both cohorts. Our analyses highlight potentially heterogeneous risks of PASC in different populations.</AbstractText><CopyrightInformation>&#xa9; 2023. The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Zang</LastName><ForeName>Chengxi</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Population Health Sciences, Weill Cornell Medicine, New York, NY, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>Yongkang</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Population Health Sciences, Weill Cornell Medicine, New York, NY, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Xu</LastName><ForeName>Jie</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Health Outcomes Biomedical Informatics, University of Florida, Gainesville, FL, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bian</LastName><ForeName>Jiang</ForeName><Initials>J</Initials><Identifier Source="ORCID">0000-0002-2238-5429</Identifier><AffiliationInfo><Affiliation>Department of Health Outcomes Biomedical Informatics, University of Florida, Gainesville, FL, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Morozyuk</LastName><ForeName>Dmitry</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Department of Population Health Sciences, Weill Cornell Medicine, New York, NY, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Schenck</LastName><ForeName>Edward J</ForeName><Initials>EJ</Initials><Identifier Source="ORCID">0000-0002-7950-5989</Identifier><AffiliationInfo><Affiliation>Department of Medicine, Division of Pulmonary and Critical Care Medicine, Weill Cornell Medicine, New York, NY, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Khullar</LastName><ForeName>Dhruv</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Department of Population Health Sciences, Weill Cornell Medicine, New York, NY, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nordvig</LastName><ForeName>Anna S</ForeName><Initials>AS</Initials><AffiliationInfo><Affiliation>Department of Neurology, Weill Cornell Medicine, New York, NY, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shenkman</LastName><ForeName>Elizabeth A</ForeName><Initials>EA</Initials><Identifier Source="ORCID">0000-0003-4903-1804</Identifier><AffiliationInfo><Affiliation>Department of Health Outcomes Biomedical Informatics, University of Florida, Gainesville, FL, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rothman</LastName><ForeName>Russell L</ForeName><Initials>RL</Initials><Identifier Source="ORCID">0000-0002-1506-3990</Identifier><AffiliationInfo><Affiliation>Center for Health Services Research, Vanderbilt University Medical Center, Nashville, TN, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Block</LastName><ForeName>Jason P</ForeName><Initials>JP</Initials><AffiliationInfo><Affiliation>Department of Population Medicine, Harvard Pilgrim Health Care Institute, Harvard Medical School, Boston, MA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lyman</LastName><ForeName>Kristin</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Louisiana Public Health Institute, New Orleans, LA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Weiner</LastName><ForeName>Mark G</ForeName><Initials>MG</Initials><Identifier Source="ORCID">0000-0001-5586-9940</Identifier><AffiliationInfo><Affiliation>Department of Population Health Sciences, Weill Cornell Medicine, New York, NY, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Carton</LastName><ForeName>Thomas W</ForeName><Initials>TW</Initials><AffiliationInfo><Affiliation>Louisiana Public Health Institute, New Orleans, LA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Fei</ForeName><Initials>F</Initials><Identifier Source="ORCID">0000-0001-9459-9461</Identifier><AffiliationInfo><Affiliation>Department of Population Health Sciences, Weill Cornell Medicine, New York, NY, USA. few2001@med.cornell.edu.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kaushal</LastName><ForeName>Rainu</ForeName><Initials>R</Initials><Identifier Source="ORCID">0000-0002-4694-2517</Identifier><AffiliationInfo><Affiliation>Department of Population Health Sciences, Weill Cornell Medicine, New York, NY, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>K23 HL151876</GrantID><Acronym>HL</Acronym><Agency>NHLBI NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>OT2 HL161847</GrantID><Acronym>HL</Acronym><Agency>NHLBI NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>04</Month><Day>07</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Nat Commun</MedlineTA><NlmUniqueID>101528555</NlmUniqueID><ISSNLinking>2041-1723</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000094024" MajorTopicYN="Y">Post-Acute COVID-19 Syndrome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D057286" MajorTopicYN="N">Electronic Health Records</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D057216" MajorTopicYN="N">Propensity Score</DescriptorName></MeshHeading></MeshHeadingList><CoiStatement>The authors declare no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>6</Month><Day>8</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>3</Month><Day>24</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>4</Month><Day>11</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>4</Month><Day>7</Day><Hour>23</Hour><Minute>14</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>4</Month><Day>8</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>4</Month><Day>7</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37029117</ArticleId><ArticleId IdType="pmc">PMC10080528</ArticleId><ArticleId IdType="doi">10.1038/s41467-023-37653-z</ArticleId><ArticleId IdType="pii">10.1038/s41467-023-37653-z</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>WHO. Coronavirus Disease (COVID-19). https://www.who.int/emergencies/diseases/novel-coronavirus-2019 (2023).</Citation></Reference><Reference><Citation>Nalbandian A, et al. Post-acute COVID-19 syndrome. Nat. Med. 2021;27:601&#x2013;615. doi: 10.1038/s41591-021-01283-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-021-01283-z</ArticleId><ArticleId IdType="pmc">PMC8893149</ArticleId><ArticleId IdType="pubmed">33753937</ArticleId></ArticleIdList></Reference><Reference><Citation>Dixit NM, Churchill A, Nsair A, Hsu JJ. Post-Acute COVID-19 syndrome and the cardiovascular system: what is known? Am. Heart J. Cardiol. Res. Pract. 2021;5:100025. doi: 10.1016/j.ahjo.2021.100025.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ahjo.2021.100025</ArticleId><ArticleId IdType="pmc">PMC8223036</ArticleId><ArticleId IdType="pubmed">34192289</ArticleId></ArticleIdList></Reference><Reference><Citation>Effiong, A. Post-acute sequelae of COVID-19 and adverse psychiatric outcomes: an etiology and risk systematic review protocol. medrXiv10.1101/2022.02.07.22270646 (2022).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10414129</ArticleId><ArticleId IdType="pubmed">37725530</ArticleId></ArticleIdList></Reference><Reference><Citation>Moghimi N, et al. The neurological manifestations of post-acute sequelae of SARS-CoV-2 infection. Curr. Neurol. Neurosci. Rep. 2021;21:44. doi: 10.1007/s11910-021-01130-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11910-021-01130-1</ArticleId><ArticleId IdType="pmc">PMC8237541</ArticleId><ArticleId IdType="pubmed">34181102</ArticleId></ArticleIdList></Reference><Reference><Citation>Aminian A, Bena J, Pantalone KM, Burguera B. Association of obesity with postacute sequelae of COVID-19. Diabetes Obes. Metab. 2021;23:2183&#x2013;2188. doi: 10.1111/dom.14454.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/dom.14454</ArticleId><ArticleId IdType="pmc">PMC8239834</ArticleId><ArticleId IdType="pubmed">34060194</ArticleId></ArticleIdList></Reference><Reference><Citation>Al-Aly Z, Xie Y, Bowe B. High-dimensional characterization of post-acute sequelae of COVID-19. Nature. 2021;594:259&#x2013;264. doi: 10.1038/s41586-021-03553-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-021-03553-9</ArticleId><ArticleId IdType="pubmed">33887749</ArticleId></ArticleIdList></Reference><Reference><Citation>Xie, Y., Xu, E., Bowe, B. &amp; Al-Aly, Z. Long-term cardiovascular outcomes of COVID-19. Nat. Med.10.1038/s41591-022-01689-3 (2022).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8938267</ArticleId><ArticleId IdType="pubmed">35132265</ArticleId></ArticleIdList></Reference><Reference><Citation>Xie Y, Xu E, Al-Aly Z. Risks of mental health outcomes in people with covid-19: cohort study. BMJ. 2022;376:e068993. doi: 10.1136/bmj-2021-068993.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj-2021-068993</ArticleId><ArticleId IdType="pmc">PMC8847881</ArticleId><ArticleId IdType="pubmed">35172971</ArticleId></ArticleIdList></Reference><Reference><Citation>Estiri H, et al. Evolving phenotypes of non-hospitalized patients that indicate long COVID. BMC Med. 2021;19:249. doi: 10.1186/s12916-021-02115-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12916-021-02115-0</ArticleId><ArticleId IdType="pmc">PMC8474909</ArticleId><ArticleId IdType="pubmed">34565368</ArticleId></ArticleIdList></Reference><Reference><Citation>Taquet M, et al. Incidence, co-occurrence, and evolution of long-COVID features: a 6-month retrospective cohort study of 273,618 survivors of COVID-19. PLoS Med. 2021;18:e1003773. doi: 10.1371/journal.pmed.1003773.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pmed.1003773</ArticleId><ArticleId IdType="pmc">PMC8478214</ArticleId><ArticleId IdType="pubmed">34582441</ArticleId></ArticleIdList></Reference><Reference><Citation>Fleurence RL, et al. Launching PCORnet, a national patient-centered clinical research network. J. Am. Med. Inform. Assoc. 2014;21:578&#x2013;582. doi: 10.1136/amiajnl-2014-002747.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/amiajnl-2014-002747</ArticleId><ArticleId IdType="pmc">PMC4078292</ArticleId><ArticleId IdType="pubmed">24821743</ArticleId></ArticleIdList></Reference><Reference><Citation>Kaushal R, et al. Changing the research landscape: the New York city clinical data research network. J. Am. Med. Inform. Assoc. 2014;21:587&#x2013;590. doi: 10.1136/amiajnl-2014-002764.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/amiajnl-2014-002764</ArticleId><ArticleId IdType="pmc">PMC4078297</ArticleId><ArticleId IdType="pubmed">24821739</ArticleId></ArticleIdList></Reference><Reference><Citation>Shenkman E, et al. OneFlorida clinical research consortium: linking a clinical and translational science institute with a community-based distributive medical education model. Acad. Med. 2018;93:451&#x2013;455. doi: 10.1097/ACM.0000000000002029.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/ACM.0000000000002029</ArticleId><ArticleId IdType="pmc">PMC5839715</ArticleId><ArticleId IdType="pubmed">29045273</ArticleId></ArticleIdList></Reference><Reference><Citation>Kind AJH, Buckingham WR. Making neighborhood-disadvantage metrics accessible&#x2014;the neighborhood atlas. N. Engl. J. Med. 2018;378:2456&#x2013;2458. doi: 10.1056/NEJMp1802313.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMp1802313</ArticleId><ArticleId IdType="pmc">PMC6051533</ArticleId><ArticleId IdType="pubmed">29949490</ArticleId></ArticleIdList></Reference><Reference><Citation>Hcup. Elixhauser Comorbidity Software Refined for ICD-10-CM. https://www.hcup-us.ahrq.gov/toolssoftware/comorbidityicd10/comorbidity_icd10.jsp (2022).</Citation></Reference><Reference><Citation>Xie Y, Bowe B, Al-Aly Z. Burdens of post-acute sequelae of COVID-19 by severity of acute infection, demographics and health status. Nat. Commun. 2021;12:6571. doi: 10.1038/s41467-021-26513-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-021-26513-3</ArticleId><ArticleId IdType="pmc">PMC8589966</ArticleId><ArticleId IdType="pubmed">34772922</ArticleId></ArticleIdList></Reference><Reference><Citation>CDC. Coronavirus Disease 2019 (COVID-19). Centers for Disease Control and Prevention.https://www.cdc.gov/coronavirus/2019-ncov/variants/variant-classifications.html (2020).</Citation></Reference><Reference><Citation>Lipsitch M, Tchetgen Tchetgen E, Cohen T. Negative controls: a tool for detecting confounding and bias in observational studies. Epidemiology. 2010;21:383&#x2013;388. doi: 10.1097/EDE.0b013e3181d61eeb.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/EDE.0b013e3181d61eeb</ArticleId><ArticleId IdType="pmc">PMC3053408</ArticleId><ArticleId IdType="pubmed">20335814</ArticleId></ArticleIdList></Reference><Reference><Citation>Shi X, Miao W, Tchetgen ET. A selective review of negative control methods in epidemiology. Curr. Epidemiol. Rep. 2020;7:190&#x2013;202. doi: 10.1007/s40471-020-00243-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s40471-020-00243-4</ArticleId><ArticleId IdType="pmc">PMC8118596</ArticleId><ArticleId IdType="pubmed">33996381</ArticleId></ArticleIdList></Reference><Reference><Citation>Benjamini Y, Yekutieli D. The control of the false discovery rate in multiple testing under dependency. Ann. Stat. 2001;29:1165&#x2013;1188. doi: 10.1214/aos/1013699998.</Citation><ArticleIdList><ArticleId IdType="doi">10.1214/aos/1013699998</ArticleId></ArticleIdList></Reference><Reference><Citation>Eilers PHC, Marx BD. Flexible smoothing with B-splines and penalties. Stat. Sci. 1996;11:89&#x2013;121. doi: 10.1214/ss/1038425655.</Citation><ArticleIdList><ArticleId IdType="doi">10.1214/ss/1038425655</ArticleId></ArticleIdList></Reference><Reference><Citation>Perperoglou A, Sauerbrei W, Abrahamowicz M, Schmid M. A review of spline function procedures in R. BMC Med. Res. Methodol. 2019;19:46. doi: 10.1186/s12874-019-0666-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12874-019-0666-3</ArticleId><ArticleId IdType="pmc">PMC6402144</ArticleId><ArticleId IdType="pubmed">30841848</ArticleId></ArticleIdList></Reference><Reference><Citation>Ke, G. et al. Advances in Neural Information Processing Systems. Vol. 30 (Curran Associates, Inc., 2017).</Citation></Reference><Reference><Citation>Taquet M, Geddes JR, Husain M, Luciano S, Harrison PJ. 6-month neurological and psychiatric outcomes in 236 379 survivors of COVID-19: a retrospective cohort study using electronic health records. Lancet Psychiatry. 2021;8:416&#x2013;427. doi: 10.1016/S2215-0366(21)00084-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2215-0366(21)00084-5</ArticleId><ArticleId IdType="pmc">PMC8023694</ArticleId><ArticleId IdType="pubmed">33836148</ArticleId></ArticleIdList></Reference><Reference><Citation>Risks and burdens of incident diabetes in long COVID: a cohort study. Lancet Diabetes Endocrinol. 10.1016/S2213-8587(22)00044-4 (2022).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8937253</ArticleId><ArticleId IdType="pubmed">35325624</ArticleId></ArticleIdList></Reference><Reference><Citation>Bowe B, Xie Y, Xu E, Al-Aly Z. Kidney outcomes in long COVID. J. Am. Soc. Nephrol. 2021;32:2851&#x2013;2862. doi: 10.1681/ASN.2021060734.</Citation><ArticleIdList><ArticleId IdType="doi">10.1681/ASN.2021060734</ArticleId><ArticleId IdType="pmc">PMC8806085</ArticleId><ArticleId IdType="pubmed">34470828</ArticleId></ArticleIdList></Reference><Reference><Citation>Chopra V, et al. Variation in COVID-19 characteristics, treatment and outcomes in Michigan: an observational study in 32 hospitals. BMJ Open. 2021;11:e044921. doi: 10.1136/bmjopen-2020-044921.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmjopen-2020-044921</ArticleId><ArticleId IdType="pmc">PMC8313307</ArticleId><ArticleId IdType="pubmed">34301650</ArticleId></ArticleIdList></Reference><Reference><Citation>Agarwal A, et al. A living WHO guideline on drugs for covid-19. BMJ. 2020;370:m3379.</Citation><ArticleIdList><ArticleId IdType="pubmed">32887691</ArticleId></ArticleIdList></Reference><Reference><Citation>Antonelli M, et al. Risk factors and disease profile of post-vaccination SARS-CoV-2 infection in UK users of the COVID Symptom Study app: a prospective, community-based, nested, case-control study. Lancet Infect. Dis. 2022;22:43&#x2013;55. doi: 10.1016/S1473-3099(21)00460-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1473-3099(21)00460-6</ArticleId><ArticleId IdType="pmc">PMC8409907</ArticleId><ArticleId IdType="pubmed">34480857</ArticleId></ArticleIdList></Reference><Reference><Citation>Cohen K, et al. Risk of persistent and new clinical sequelae among adults aged 65 years and older during the post-acute phase of SARS-CoV-2 infection: retrospective cohort study. BMJ. 2022;376:e068414. doi: 10.1136/bmj-2021-068414.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj-2021-068414</ArticleId><ArticleId IdType="pmc">PMC8828141</ArticleId><ArticleId IdType="pubmed">35140117</ArticleId></ArticleIdList></Reference><Reference><Citation>CDC. All About Adult BMI.Centers for Disease Control and Prevention.https://www.cdc.gov/healthyweight/assessing/bmi/adult_bmi/index.html (2022).</Citation></Reference><Reference><Citation>Xu S, et al. Use of stabilized inverse propensity scores as weights to directly estimate relative risk and its confidence intervals. Value Health. 2010;13:273&#x2013;277. doi: 10.1111/j.1524-4733.2009.00671.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1524-4733.2009.00671.x</ArticleId><ArticleId IdType="pmc">PMC4351790</ArticleId><ArticleId IdType="pubmed">19912596</ArticleId></ArticleIdList></Reference><Reference><Citation>Austin PC, Stuart EA. Moving towards best practice when using inverse probability of treatment weighting (IPTW) using the propensity score to estimate causal treatment effects in observational studies. Stat. Med. 2015;34:3661&#x2013;3679. doi: 10.1002/sim.6607.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/sim.6607</ArticleId><ArticleId IdType="pmc">PMC4626409</ArticleId><ArticleId IdType="pubmed">26238958</ArticleId></ArticleIdList></Reference><Reference><Citation>Zang, C. et al. High-Throughput Clinical Trial Emulation with Real World Data and Machine Learning: A Case Study of Drug Repurposing for Alzheimer&#x2019;s Disease. 2022.01.31.22270132 Preprint at 10.1101/2022.01.31.22270132 (2022).</Citation></Reference><Reference><Citation>Aalen OO, Johansen S. An empirical transition matrix for non-homogeneous Markov chains based on censored observations. Scand. J. Stat. 1978;5:141&#x2013;150.</Citation></Reference><Reference><Citation>Zang, C. calvin-zcx/pasc_phenotype: Code Screen. Long. Covid.10.5281/zenodo.7742990 (2023).</Citation></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>